<DOC>
	<DOCNO>NCT01363271</DOCNO>
	<brief_summary>This retrospective , observational , non-interventional drug study use de-identified data two administrative claim datasets . The study design analysis reflect perspective commercially insure . The objective study twofold : 1 . To compare rate re-hospitalization among patient treat either linezolid orally IV , vancomycin IV complicate skin skin structure infection ( cSSSI ) pneumonia hospitalization . 2 . To compare total direct medical cost patient treat linezolid orally IV , vancomycin IV cSSSI pneumonia hospitalization .</brief_summary>
	<brief_title>Cost Study Linezolid Versus Vancomycin Among Previously Hospitalized Patients</brief_title>
	<detailed_description>A sampling method use study since retrospective , non-interventional claim database analysis . Pre-specified inclusion/exclusion criterion ICD-9 , NDC , HCPC cod apply identify study cohort .</detailed_description>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Linezolid</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<criteria>Subjects must meet follow inclusion criterion eligible enrollment study : Patients hospitalization cSSSI pneumonia discharge date ( i.e . index date ) January 1 , 2007 September 30 , 2009 . Patient must claim either vancomycin ( IV ) linezolid ( IV oral ) within 7 day follow cSSSI pneumonia hospitalization discharge date ( i.e . index date ) . We exclude patient initially receive vancomycin linezolid day . We apply intentiontotreat approach use first drug index drug , even `` comparator drug '' ( e.g . vancomycin linezolid viceversa ) use subsequently future date . If oral IV formulation index drug index date , patient keep categorized IV user . As duplicate claim , two claim oral IV index drug well IV oral cost index date , claim oral drug remove , patient call IV user . 1864 year age index date . Continuous eligibility six month prior index hospitalization date . No minimum postindex continuous enrolment require assure early mortality patient include ( maximum 180 day index vancomycin linezolid claim ) . Subjects present follow include study : Patients enrol Medicare . Patients age 65 young 18 . Patients few 3 day oral therapy . Patients index hospitalization great 30 day . Patients osteomyelitis , infective endocarditis , meningitis , joint infection , necrotizing fasciitis , gangrene , prosthetic joint infection , prosthetic implant/ device infection index hospitalization .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>May 2012</verification_date>
</DOC>